HUP0104944A2 - Acetamidot és szubsztituált acetamidot tartalmazó tiokarbamidok, mint herpeszvírus inhibitorok és ezeket tartalmazó gyógyszerkészítmények - Google Patents

Acetamidot és szubsztituált acetamidot tartalmazó tiokarbamidok, mint herpeszvírus inhibitorok és ezeket tartalmazó gyógyszerkészítmények

Info

Publication number
HUP0104944A2
HUP0104944A2 HU0104944A HUP0104944A HUP0104944A2 HU P0104944 A2 HUP0104944 A2 HU P0104944A2 HU 0104944 A HU0104944 A HU 0104944A HU P0104944 A HUP0104944 A HU P0104944A HU P0104944 A2 HUP0104944 A2 HU P0104944A2
Authority
HU
Hungary
Prior art keywords
group
carbon atoms
acetamide
hydrogen atom
herpes viruses
Prior art date
Application number
HU0104944A
Other languages
English (en)
Inventor
Jonathan David Bloom
Martin Joseph Digrandi
Russell George Dushin
Stanley Albert Lang
Bryan Mark O'hara
Original Assignee
American Home Products Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corporation filed Critical American Home Products Corporation
Publication of HUP0104944A2 publication Critical patent/HUP0104944A2/hu
Publication of HUP0104944A3 publication Critical patent/HUP0104944A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04Derivatives of thiourea
    • C07C335/16Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/20Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04Derivatives of thiourea
    • C07C335/16Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/22Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Furan Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Quinoline Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Az (1) ltal nos képletű vegyületek - a képletben R1-R5 jelentése egymstól függetlenül hidrogénatom, 1-6 szénatomos alkilcsoport, 2-6szénatomos alkenilcsoport, 2-6 szénatomos alkinilcsoport, 1-6szénatomos perhalogénalkilcsoport, 3-10 szénatomos cikloalkilcsoport,3-10 gyűrű-szénatomot tartalmazó heterocikloalkilcsoport, arilcsoport,heteroarilcsoport, halogénatom, -CN, -NO2, -CO2R6, -COR6, -OR6, -SR6,-SOR6, -SO2R6, -CONR7R8, -NR6N(R7R8), -N(R7R8) vagy W-Y-(CH2)n-Z ltalnos képletű csoport, azzal a megk"téssel, hogy az R1-R5szubsztituensek legal bb egyike hidrogénatomtól eltérő; vagy R2 és R3vagy R3 és R4 együtt 3-7 tagú heterocikloalkilcsoportot vagy 3-7 tagúheteroarilcsoportot alkotnak; R9-R12 jelentése egym stól függetlenülhidrogénatom, 1-4 szénatomos alkilcsoport, 1-4 szénatomosperhalogénalkilcsoport, halogénatom, 1-4 szénatomos alkoxicsoport vagycianocsoport, vagy R9 és R10 vagy R11 és R12 együtt 5-7 szénatomosarilcsoportot alkotnak; G jelentése 1-6 szénatomos alkilcsoport és Xjelentése kémiai k"tés, -NH, 1-6 szénatomos alkilcsoport, 1-6szénatomos alkenilcsoport, 1-6 szénatomos alkoxicsoport, 1-6szénatomos tioalkilcsoport, 1-6 szénatomos alkilaminocsoport vagy(CH)J és gyógy szatilag elfogadható sóik herpeszvírusok szaporod s t gtló aktivit ssal rendelkeznek, fenti aktivit suk k"vetkeztében gyógyszati készítmények hatóanyagaként alkalmazhatók. Ó
HU0104944A 1998-12-09 1999-12-06 Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses HUP0104944A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20831698A 1998-12-09 1998-12-09
PCT/US1999/028844 WO2000034237A2 (en) 1998-12-09 1999-12-06 Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses

Publications (2)

Publication Number Publication Date
HUP0104944A2 true HUP0104944A2 (hu) 2002-04-29
HUP0104944A3 HUP0104944A3 (en) 2003-03-28

Family

ID=22774137

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0104944A HUP0104944A3 (en) 1998-12-09 1999-12-06 Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses

Country Status (15)

Country Link
EP (1) EP1137633A2 (hu)
JP (1) JP2002531544A (hu)
KR (1) KR20010087413A (hu)
CN (1) CN1333750A (hu)
AU (1) AU3111200A (hu)
BR (1) BR9916041A (hu)
CA (1) CA2350899A1 (hu)
CZ (1) CZ20012060A3 (hu)
EA (1) EA200100640A1 (hu)
HU (1) HUP0104944A3 (hu)
IL (1) IL143204A0 (hu)
NO (1) NO20012834L (hu)
PL (1) PL349131A1 (hu)
WO (1) WO2000034237A2 (hu)
ZA (1) ZA200104142B (hu)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6166028A (en) * 1998-12-09 2000-12-26 American Home Products Corporation Diaminopuridine-containing thiourea inhibitors of herpes viruses
US6844367B1 (en) 1999-09-17 2005-01-18 Millennium Pharmaceuticals, Inc. Benzamides and related inhibitors of factor Xa
DK1259485T3 (da) 2000-02-29 2006-04-10 Millennium Pharm Inc Benzamider og beslægtede inhibitorer for faktor Xa
CN1705645A (zh) * 2002-10-24 2005-12-07 默克专利有限公司 作为raf-激酶抑制剂的亚甲基脲衍生物
US7220768B2 (en) * 2003-02-11 2007-05-22 Wyeth Holdings Corp. Isoxazole-containing thiourea inhibitors useful for treatment of varicella zoster virus
CA2534352A1 (en) 2003-08-08 2005-02-17 Arriva Pharmaceuticals, Inc. Methods of protein production in yeast
CA2904555C (en) 2003-08-29 2017-03-07 Mitsui Chemicals, Inc. Agricultural/horticultural insecticide and method for using the same
CA2559062A1 (en) 2004-03-09 2005-09-22 Arriva Pharmaceuticals, Inc. Treatment of chronic obstructive pulmonary disease by low dose inhalation of protease inhibitor
US20100093864A1 (en) * 2006-10-13 2010-04-15 Lica Pharmaceuticals Anti-infective thiourea compounds
WO2008057972A1 (en) 2006-11-02 2008-05-15 Millennium Pharmaceuticals, Inc. Methods of synthesizing pharmaceutical salts of a factor xa inhibitor
CN108619123A (zh) * 2018-03-13 2018-10-09 武汉威立得生物医药有限公司 Tenovin-1在制备防治人类疱疹病毒感染药物中的应用
WO2019193541A1 (en) * 2018-04-06 2019-10-10 Glaxosmithkline Intellectual Property Development Limited Bicyclic aromatic ring derivatives of formula (i) as atf4 inhibitors
CN112807294B (zh) * 2019-11-18 2023-09-05 武汉大学 一种酰基硫脲类化合物在制备治疗或预防单纯疱疹病毒i型感染药物中的应用
WO2022150962A1 (en) * 2021-01-12 2022-07-21 Westlake Pharmaceutical (Hangzhou) Co., Ltd. Protease inhibitors, preparation, and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001519808A (ja) * 1997-04-10 2001-10-23 ファルマシア・アンド・アップジョン・カンパニー ポリ芳香族抗菌組成物

Also Published As

Publication number Publication date
AU3111200A (en) 2000-06-26
CA2350899A1 (en) 2000-06-15
ZA200104142B (en) 2002-10-25
NO20012834D0 (no) 2001-06-08
WO2000034237A2 (en) 2000-06-15
BR9916041A (pt) 2001-12-04
EA200100640A1 (ru) 2001-12-24
IL143204A0 (en) 2002-04-21
KR20010087413A (ko) 2001-09-15
WO2000034237A3 (en) 2000-11-23
PL349131A1 (en) 2002-07-01
CZ20012060A3 (cs) 2001-11-14
CN1333750A (zh) 2002-01-30
EP1137633A2 (en) 2001-10-04
JP2002531544A (ja) 2002-09-24
HUP0104944A3 (en) 2003-03-28
NO20012834L (no) 2001-08-07

Similar Documents

Publication Publication Date Title
HUP0104944A2 (hu) Acetamidot és szubsztituált acetamidot tartalmazó tiokarbamidok, mint herpeszvírus inhibitorok és ezeket tartalmazó gyógyszerkészítmények
GR861572B (en) Tricyclodecanen (meth)-acrylic acid derivatives and use therefor
FI892787A (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-indolyylialkyyli-4-(substituoitu pyridinyyli)piperatsiinien valmistamiseksi
HUP9903336A2 (hu) Szulfonsav-N-[(amino-imino-metil)-fenil]-aza-heretero-ciklil-amid származékok és az ezeket tartalmazó gyógyszerkészítmények
DK164704C (da) 3,6-disubstituerede triazolo-oe3,4-aaa-ftalazinderivater, fremgangsmaade til fremstilling deraf, udgangsforbindelse til anvendelse i fremgangsmaaden samt anvendelse af og farmaceutisk praeparat indeholdende forbindelserne
DE3876813T4 (de) 3(2H)Pyridazinon, Verfahren zu dessen Herstellung und dieses enthaltendes Mittel gegen SRS-A.
EP0154234A3 (en) Substituted tyrosil alanine dipeptide amides
DE3888340D1 (de) Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit.
ES8801197A1 (es) Procedimiento para la obtencion de esteres de acido sulfurico
HUP0003577A2 (hu) Tetrahidro-gamma-karbolinok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
CA1249830A (en) ANTIHISTAMINES WITH DIPHENYL AND PHENYLPYRIDYL GROUPS
HUP0103751A2 (hu) Epesavval helyettesített fenilalkenoilguanidinek, valamint e vegyületeket tartalmazó gyógyászati készítmények és eljárás ezek előállítására
CA2364719A1 (en) 2-aminopyridines containing fused ring substituents
ATE179071T1 (de) Verwendung eines thioesters zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von ischämie und von reperfusion-syndromen
HUP0004317A2 (hu) 5-HT1F agonisták
HUP0104624A2 (hu) Nukleotid szintézis-inhibítorokat tartalmazó, javított terápiás szélességű készítmény
ZA944256B (en) Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
FI955680A0 (fi) Psoraleenijohdannaiset, niiden valmistus ja käyttö
DK162214C (da) Analogifremgangsmaade til fremstilling af en ren enantiomer af 3-fenyl-n-n-propylpiperidinderivater
HUP0201374A2 (hu) Új piperidinil-alkil-amino-piridazinon-származékok, ilyen hatóanyagot tartalmazó gyógyászati készítmények, és eljárás a hatóanyag előállítására
GB1490666A (en) Dioxamic acid derivatives
DE3877361D1 (de) Aminosalze von alkan-1,n-dicarbonsaeure-mono-(2-sulfato-aethyl)amiden.
TH1819B (th) การเตรียมอนุพันธ์ 1-แอลคิล-2-อะมิโน-เททราลิน